Gossamer Bio, Inc.

Home » Gossamer Bio, Inc.

IPO

Gossamer Bio, Inc.

We are a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology.

Symbol

GOSS

Price Range
$16.00 - $16.00

Final Shares
14,375,000

Effective Date
February 8, 2019

Underwriters
BofA Merrill Lynch, Leerink Partners, Barclays, Evercore ISI

To view the prospectus for Gossamer Bio, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253